CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 87.41% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Scan to Download iOS&Android APP

Trade Adial Pharmaceuticals, Inc. - ADIL CFD

1.11
0%
  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.25
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.0308 %
Charges from borrowed part ($-1.23)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.0308%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.0308 %
Charges from borrowed part ($-1.23)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.0137%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 20%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* N/A
Open* N/A
1-Year Change* N/A
Day's Range* N/A
52 wk Range 0.24-3.14
Average Volume (10 days) 0.11555
Average Volume (3 months) 3.07896
Market Cap 7.68023
P/E Ratio N/A
Shares Outstanding 26854000
Revenue N/A
EPS -0.68555
Dividend (Yield %) N/A
Beta 0.55517
Next Earnings Date N/A

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jun 27, 2022 1.11 0.01 0.91% 1.10 1.11 1.10
May 24, 2022 1.17 0.00 0.00% 1.17 1.17 1.17
Feb 24, 2022 1.86 0.00 0.00% 1.86 1.87 1.82
Feb 11, 2022 2.15 -0.20 -8.51% 2.35 2.38 2.11
Feb 10, 2022 2.48 0.19 8.30% 2.29 2.48 2.20
Feb 9, 2022 2.39 -0.17 -6.64% 2.56 2.56 2.33
Feb 8, 2022 2.34 0.06 2.63% 2.28 2.36 2.26
Feb 7, 2022 2.31 -0.01 -0.43% 2.32 2.40 2.28
Feb 4, 2022 2.32 0.23 11.00% 2.09 2.32 2.03
Feb 3, 2022 2.07 -0.09 -4.17% 2.16 2.16 2.03
Feb 2, 2022 2.15 -0.08 -3.59% 2.23 2.25 2.13
Feb 1, 2022 2.21 0.15 7.28% 2.06 2.23 2.03
Jan 31, 2022 2.05 -0.12 -5.53% 2.17 2.20 2.04
Jan 28, 2022 2.13 0.00 0.00% 2.13 2.18 2.08
Jan 27, 2022 2.22 -0.01 -0.45% 2.23 2.25 2.10
Jan 26, 2022 2.26 -0.01 -0.44% 2.27 2.35 2.09
Jan 25, 2022 2.26 -0.05 -2.16% 2.31 2.33 2.19
Jan 24, 2022 2.29 0.06 2.69% 2.23 2.33 1.98
Jan 21, 2022 2.31 -0.11 -4.55% 2.42 2.43 2.20
Jan 20, 2022 2.45 -0.02 -0.81% 2.47 2.58 2.38

Adial Pharmaceuticals, Inc. Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total revenue 0 0 0 0 0 0
Total Operating Expense 0.41081 0.99529 10.4717 8.2449 10.928 19.2596
Selling/General/Admin. Expenses, Total 0.26466 0.81318 6.61876 4.27936 5.07469 9.34468
Research & Development 0.14614 0.18211 0.36846 3.96554 5.85329 8.39565
Operating Income -0.41081 -0.99529 -10.4717 -8.2449 -10.928 -19.2596
Interest Income (Expense), Net Non-Operating -0.00939 -0.14417 -1.15966 0.09523 0.0325 0.00654
Net Income Before Taxes -0.4202 -1.13946 -11.6314 -8.59143 -10.893 -19.5174
Net Income After Taxes -0.4202 -1.13946 -11.6314 -8.59143 -10.893 -19.4233
Net Income Before Extra. Items -0.4202 -1.13946 -11.6314 -8.59143 -10.893 -19.4233
Net Income -0.4202 -1.13946 -11.6314 -8.59143 -10.893 -19.4233
Income Available to Common Excl. Extra. Items -0.4202 -1.13946 -11.6314 -8.59143 -10.893 -19.4233
Income Available to Common Incl. Extra. Items -0.4202 -1.13946 -11.6314 -8.59143 -10.893 -19.4233
Diluted Net Income -0.4202 -1.13946 -11.6314 -8.59143 -10.893 -19.4233
Diluted Weighted Average Shares 6.53822 6.53822 4.75936 9.85249 12.4631 18.5888
Diluted EPS Excluding Extraordinary Items -0.06427 -0.17428 -2.44389 -0.87201 -0.87402 -1.0449
Dividends per Share - Common Stock Primary Issue 0 0
Diluted Normalized EPS -0.06427 -0.17428 -1.71176 -0.87201 -0.87402 -0.99177
Total Extraordinary Items 0
Unusual Expense (Income) 3.4845 0 1.51931
Other, Net -0.44176 0.0025 -0.26431
Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1 2022
Total revenue 0 0 0 0 0
Total Operating Expense 4.84033 4.40373 4.06353 5.98114 3.05895
Selling/General/Admin. Expenses, Total 2.78871 2.08468 2.37184 2.09945 2.46261
Research & Development 2.05162 2.31905 1.69169 2.33329 0.59634
Operating Income -4.84033 -4.40373 -4.06353 -5.98114 -3.05895
Interest Income (Expense), Net Non-Operating 0.0003 0.00118 0.00286 0.0022 0.00512
Other, Net 0.00628 -0.03839 -0.25712 0.05401 0.146
Net Income Before Taxes -4.83376 -4.44093 -4.31778 -5.92492 -2.90784
Net Income After Taxes -4.83376 -4.44093 -4.31778 -5.83084 -2.90784
Net Income Before Extra. Items -4.83376 -4.44093 -4.31778 -5.83084 -2.90784
Net Income -4.83376 -4.44093 -4.31778 -5.83084 -2.90784
Income Available to Common Excl. Extra. Items -4.83376 -4.44093 -4.31778 -5.83084 -2.90784
Income Available to Common Incl. Extra. Items -4.83376 -4.44093 -4.31778 -5.83084 -2.90784
Diluted Net Income -4.83376 -4.44093 -4.31778 -5.83084 -2.90784
Diluted Weighted Average Shares 15.9119 17.5888 19.8481 20.7612 23.1512
Diluted EPS Excluding Extraordinary Items -0.30378 -0.25249 -0.21754 -0.28085 -0.1256
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.30378 -0.25249 -0.21754 -0.23238 -0.1256
Unusual Expense (Income) 1.5484
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total Current Assets 0.14141 0.02725 4.69255 7.67347 5.13584 6.46161
Cash and Short Term Investments 0.08799 0.01825 3.86904 6.77705 4.40111 6.06217
Cash & Equivalents 0.08799 0.01825 3.86904 6.77705 4.40111 6.06217
Total Receivables, Net 0.03512 0
Prepaid Expenses 0.0183 0.009 0.82351 0.89642 0.73472 0.39943
Total Assets 0.15153 0.03455 4.69929 7.67964 5.49144 7.47498
Intangibles, Net 0.00786 0.0073 0.00674 0.00617 0.00561 0.46004
Other Long Term Assets, Total 0.00225 0
Total Current Liabilities 0.25502 1.0321 0.25797 0.53905 1.50538 2.72239
Payable/Accrued 0.02001 0.34208 0.25797
Notes Payable/Short Term Debt 0.23426 0.68927 0 0 0 0
Other Current Liabilities, Total 0.00075 0.00075 0 0.00968
Total Liabilities 0.25502 1.0321 0.25797 0.53905 1.50538 3.96716
Total Long Term Debt 0 0 0 0 0 0
Total Equity -0.10349 -0.99755 4.44131 7.14059 3.98607 3.50781
Common Stock 0.00326 0.00327 0.00686 0.01037 0.01439 0.02095
Additional Paid-In Capital 9.83149 -0.59683 16.4698 27.757 35.4915 54.43
Retained Earnings (Accumulated Deficit) -9.93825 -0.40399 -12.0354 -20.6268 -31.5198 -50.9431
Total Liabilities & Shareholders’ Equity 0.15153 0.03455 4.69929 7.67964 5.49144 7.47498
Total Common Shares Outstanding 6.53822 6.53822 6.8625 10.3684 14.3931 20.9467
Accounts Payable 0.1902 0.64874 0.28619
Accrued Expenses 0.34885 0.85664 2.42652
Note Receivable - Long Term 0.35 0
Property/Plant/Equipment, Total - Net 0.30436
Goodwill, Net 0.24897
Deferred Income Tax 0.0234
Other Liabilities, Total 1.22138
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Total Current Assets 6.1723 5.58995 7.98553 6.46161 12.965
Cash and Short Term Investments 5.63791 5.20985 7.18021 6.06217 12.6892
Cash & Equivalents 5.63791 5.20985 7.18021 6.06217 12.6892
Prepaid Expenses 0.53439 0.38011 0.80532 0.39943 0.27583
Total Assets 8.6255 8.06292 10.4462 7.47498 13.9636
Property/Plant/Equipment, Total - Net 0.31284 0.33275 0.32061 0.30436 0.28979
Goodwill, Net 0.1315 0.1315 0.1315 0.24897 0.24897
Intangibles, Net 2.00886 2.00872 2.00858 0.46004 0.4599
Note Receivable - Long Term 0 0 0 0
Total Current Liabilities 2.04234 2.21323 1.95785 2.72239 2.17113
Accounts Payable 0.6374 0.47741 0.18519 0.28619 0.41509
Accrued Expenses 1.37585 1.73582 1.77266 2.42652 1.74618
Notes Payable/Short Term Debt 0.02909 0 0 0 0
Total Liabilities 3.00786 3.23391 3.24611 3.96716 3.25632
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 0.96552 1.02069 1.28826 1.22138 1.0618
Total Equity 5.61764 4.829 7.2001 3.50781 10.7073
Common Stock 0.01727 0.01841 0.02045 0.02095 0.02372
Additional Paid-In Capital 41.9539 45.6051 52.2919 54.43 64.5346
Retained Earnings (Accumulated Deficit) -36.3535 -40.7945 -45.1123 -50.9431 -53.8509
Total Liabilities & Shareholders’ Equity 8.6255 8.06292 10.4462 7.47498 13.9636
Total Common Shares Outstanding 17.2699 18.4057 20.4482 20.9467 20.9467
Other Current Liabilities, Total 0.00968 0.00986
Deferred Income Tax 0.0234 0.0234
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Net income/Starting Line -0.4202 -1.13946 -11.6314 -8.59143 -10.893 -19.4233
Cash From Operating Activities -0.27438 -0.49486 -2.49839 -6.33861 -7.63316 -11.9494
Amortization 0.00057 0.00057 0.00056 0.00057 0.00056 0.00057
Non-Cash Items 0.15357 0.30766 9.98174 2.04408 2.01425 6.08952
Cash Taxes Paid 0 0 0 0 0 0
Cash Interest Paid 0 0 0.03816 0 0 0
Changes in Working Capital -0.00832 0.33637 -0.84932 0.20817 1.24502 1.47143
Cash From Investing Activities 0 0.03512 0 -0.35 -0.03402
Other Investing Cash Flow Items, Total 0 0.03512 0 -0.35 0.03059
Cash From Financing Activities 0.2 0.39 6.34918 9.24662 5.60722 13.6445
Issuance (Retirement) of Debt, Net 0.2 0.35 -0.075 0
Net Change in Cash -0.07438 -0.06975 3.8508 2.90801 -2.37594 1.66106
Issuance (Retirement) of Stock, Net 0.04 6.42418 9.24662 5.60722 13.6445
Cash From Operating Activities 0.00646
Deferred Taxes -0.09408
Capital Expenditures -0.06461
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line -4.83376 -9.2747 -13.5925 -19.4233 -2.90784
Cash From Operating Activities -2.84342 -6.04676 -9.5764 -11.9494 -2.49675
Cash From Operating Activities 0.00066 0.00259 0.00259 0.00646 0.00193
Amortization 0.00014 0.00028 0.00042 0.00057 0.00014
Non-Cash Items 1.33008 2.22366 3.6992 6.08952 0.85025
Cash Taxes Paid 0 0 0 0 0
Cash Interest Paid 0 0 0 0 0
Changes in Working Capital 0.65946 1.00141 0.31387 1.47143 -0.44124
Cash From Investing Activities -0.00029 -0.03402 -0.03402 -0.03402 0
Capital Expenditures -0.03088 -0.06461 -0.06461 -0.06461 0
Other Investing Cash Flow Items, Total 0.03059 0.03059 0.03059 0.03059 0
Cash From Financing Activities 4.0805 6.8895 12.3895 13.6445 9.12374
Issuance (Retirement) of Stock, Net 4.0805 6.8895 12.3895 13.6445 9.12374
Net Change in Cash 1.23679 0.80873 2.77909 1.66106 6.62699
Deferred Taxes -0.09408
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Stilley (William B. III) Individual Investor 4.4226 1187646 0 2022-08-18 LOW
Claiborne (Cary J) Individual Investor 4.0962 1100000 100000 2022-09-20 LOW
Peikin (Mark Howard) Individual Investor 2.3646 635000 -711741 2021-12-31
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 2.2971 616855 26003 2022-09-30 LOW
Newman (James W. Jr.) Individual Investor 1.2604 338463 0 2022-08-18 LOW
Citadel Advisors LLC Hedge Fund 0.987 265062 265062 2022-09-30 HIGH
En Fideicomiso De Mi Vida Trust Corporation 0.9815 263566 0 2022-08-18 LOW
Johnson (Bankole A) Individual Investor 0.9716 260908 0 2022-08-18 MED
BlackRock Institutional Trust Company, N.A. Investment Advisor 0.8253 221629 -945 2022-09-30 LOW
Renaissance Technologies LLC Hedge Fund 0.5371 144230 -25170 2022-09-30 HIGH
MVA 151 Investors, L.L.C. Corporation 0.537 144200 0 2022-08-18 LOW
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.5119 137464 1575 2022-09-30 LOW
Truluck (Joseph) Individual Investor 0.4008 107639 0 2022-08-18 LOW
Virtu Americas LLC Research Firm 0.2893 77694 45681 2022-09-30 HIGH
Two Sigma Investments, LP Hedge Fund 0.2837 76191 76191 2022-09-30 HIGH
Group One Trading, L.P. Research Firm 0.2109 56622 43433 2022-09-30 HIGH
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.195 52354 0 2022-09-30 LOW
Oppenheimer Asset Management Inc. Investment Advisor 0.1434 38500 0 2022-09-30 LOW
Commonwealth Financial Network Investment Advisor 0.1358 36461 0 2022-09-30 LOW
UBS Financial Services, Inc. Investment Advisor 0.1323 35517 35517 2022-09-30 LOW

Why choose Capital.com? Our numbers speak for themselves.

Capital.com Group
475000+

Traders

71000+

Active clients monthly

$51000000+

Monthly investing volume

$30000000+

Withdrawn each month

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

Adial Pharmaceuticals, Inc. Company profile

About Adial Pharmaceuticals Inc

Adial Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the development of medications for the treatment of addictions and related disorders. Its lead investigational drug product is AD04. AD04 is being developed for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist. AD04 is being designed to be used for the treatment of other addictive disorders, such as opioid use disorder, obesity, smoking, and other drug addictions.

Financial summary

BRIEF: For the nine months ended 30 September 2021, Adial Pharmaceuticals Inc revenues was not reported. Net loss increased 83% to $13.6M. Higher net loss reflects General and Administrative Expenses increase from $2.2M to $4.8M (expense), Research and development expenses - increase of 62% to $5.8M (expense), Equity-based compensation increase of 72% to $2.5M (expense).

Industry: Bio Therapeutic Drugs

1180 Seminole Trail
Suite 495
CHARLOTTESVILLE
VIRGINIA 22901
US

Income Statement

People also watch

BTC/USD

17,247.35 Price
+0.110% 1D Chg, %
Long position overnight fee -0.0500%
Short position overnight fee 0.0140%
Overnight fee time 22:00 (UTC)
Spread 60.00

Natural Gas

5.88 Price
-0.190% 1D Chg, %
Long position overnight fee 0.0554%
Short position overnight fee -0.0830%
Overnight fee time 22:00 (UTC)
Spread 0.005

Oil - Crude

71.77 Price
-0.330% 1D Chg, %
Long position overnight fee -0.0086%
Short position overnight fee -0.0054%
Overnight fee time 22:00 (UTC)
Spread 0.03

XRP/USD

0.39 Price
-0.270% 1D Chg, %
Long position overnight fee -0.0500%
Short position overnight fee 0.0140%
Overnight fee time 22:00 (UTC)
Spread 0.00334

Still looking for a broker you can trust?

Join the 475.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading